Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Hydrocortisone rapidly and significantly reduces the IL-6 level in blood and lungs of patients with COVID-19-related ARDS

Fig. 1

Effect of hydrocortisone treatment on pro-inflammatory cytokine kinetics. IL-6, TNF-α, and IL-1β concentrations were measured in blood and supernatants of endotracheal aspirates of patients with COVID-19-related ARDS before and after the start of hydrocortisone or placebo administration. Red lines represent trend graphs; blue dot lines represent confidence intervals. The p-value linked to the regression analysis with interaction evaluates the statistical significance of the observed changes in cytokine concentrations after administering hydrocortisone or a placebo. A p-value less than 0.05 indicates a significant effect

Back to article page

Critical Care

ISSN: 1364-8535